Truck driver Oswaldo Monroy, 62, is examined for COVID-19 at an Worldwide Brotherhood of Teamsters testing website, because the unfold of the coronavirus illness (COVID-19) continues, in Wilmington, close to the Port of Los Angeles, California, June 25, 2020.
Lucy Nicholson | Reuters
The Meals and Drug Administration announced on Friday that it has approved the primary serology take a look at that screens for neutralizing antibodies brought on by a earlier coronavirus an infection.
Neutralizing antibodies stop viruses from infecting cells, although questions stay about how lengthy antibodies towards Covid-19 final and the way a lot safety they supply. The brand new serology take a look at will assist researchers research the neutralizing antibodies, mentioned Dr. Tim Stenzel, director of the Workplace of In Vitro Diagnostics and Radiological Well being within the FDA’s Heart for Units and Radiological Well being.
“The power to detect neutralizing antibodies may also help us acquire extra perception into what the existence of antibodies might imply for sufferers as we proceed the struggle towards COVID-19,” he mentioned in an announcement. “There are nonetheless many unknowns about what the presence of SARS-CoV-2 antibodies might inform us about potential immunity, however right now’s authorization offers us one other instrument to guage these antibodies as we proceed to analysis and research this virus.”
Sufferers and well being suppliers mustn’t interpret the constructive outcomes of the take a look at to imply that sufferers are protected towards Covid-19, the company mentioned. They need to nonetheless comply with public well being precautions, the FDA mentioned.
The FDA granted the emergency use authorization to GenScript USA, which manufactures the take a look at.